| Primary |
| Asthma |
44.3% |
| Drug Use For Unknown Indication |
16.2% |
| Product Used For Unknown Indication |
10.1% |
| Chronic Obstructive Pulmonary Disease |
8.5% |
| Hiv Infection |
8.0% |
| Cough |
2.1% |
| Hypertension |
1.8% |
| Insomnia |
1.3% |
| Hypersensitivity |
1.0% |
| Atrial Fibrillation |
0.8% |
| Depression |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Type 2 Diabetes Mellitus |
0.8% |
| Back Pain |
0.5% |
| Bacterial Infection |
0.5% |
| Bronchiectasis |
0.5% |
| Dementia Alzheimer's Type |
0.5% |
| Dermatosis |
0.5% |
| Epilepsy |
0.5% |
| Parkinson's Disease |
0.5% |
|
| Product Quality Issue |
17.6% |
| Death |
12.7% |
| Weight Decreased |
6.9% |
| Pharmaceutical Product Complaint |
5.9% |
| Abortion Spontaneous |
4.9% |
| Osteonecrosis |
4.9% |
| Respiratory Failure |
4.9% |
| Spinal Compression Fracture |
4.9% |
| Asthma |
3.9% |
| Weight Increased |
3.9% |
| Chronic Obstructive Pulmonary Disease |
2.9% |
| Diabetes Mellitus Inadequate Control |
2.9% |
| Myocardial Infarction |
2.9% |
| Pneumonia |
2.9% |
| Respiratory Disorder |
2.9% |
| Skin Striae |
2.9% |
| Syndactyly |
2.9% |
| Tachycardia |
2.9% |
| Transaminases Increased |
2.9% |
| Tremor |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
23.8% |
| Asthma |
20.8% |
| Drug Use For Unknown Indication |
7.7% |
| Hypertension |
7.7% |
| Chronic Obstructive Pulmonary Disease |
5.4% |
| Infection |
5.4% |
| Atrial Fibrillation |
3.8% |
| Staphylococcal Infection |
3.8% |
| Bacterial Infection |
2.3% |
| Epilepsy |
2.3% |
| Hyperuricaemia |
2.3% |
| Hypothyroidism |
2.3% |
| Prophylaxis |
2.3% |
| Prophylaxis Against Transplant Rejection |
2.3% |
| Osteoporosis |
1.5% |
| Parkinson's Disease |
1.5% |
| Superinfection |
1.5% |
| Ulcer |
1.5% |
| Anxiety |
0.8% |
| Blood Uric Acid |
0.8% |
|
| Thrombocytopenic Purpura |
11.1% |
| Breast Cancer |
7.4% |
| Hiatus Hernia |
7.4% |
| Mastectomy |
7.4% |
| Transaminases Increased |
7.4% |
| Vision Blurred |
7.4% |
| Asthma |
3.7% |
| Blood Bicarbonate Decreased |
3.7% |
| Bronchitis |
3.7% |
| Eosinophilia |
3.7% |
| Headache |
3.7% |
| Hepatitis |
3.7% |
| Hypokalaemia |
3.7% |
| Infertility Male |
3.7% |
| Laryngeal Cancer |
3.7% |
| Malaise |
3.7% |
| Nasopharyngitis |
3.7% |
| Rash |
3.7% |
| Sensory Disturbance |
3.7% |
| Tremor |
3.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
39.4% |
| Asthma |
18.9% |
| Product Used For Unknown Indication |
9.6% |
| Hypertension |
7.1% |
| Chronic Obstructive Pulmonary Disease |
5.2% |
| Bronchitis |
2.9% |
| Joint Prosthesis User |
2.2% |
| Depression |
1.7% |
| Hypercholesterolaemia |
1.7% |
| Pain |
1.7% |
| Cystic Fibrosis |
1.2% |
| Atrial Fibrillation |
1.1% |
| Cardiac Disorder |
1.1% |
| Diabetes Mellitus |
1.0% |
| Hypersensitivity |
1.0% |
| Premedication |
1.0% |
| Prophylaxis |
1.0% |
| Ankylosing Spondylitis |
0.8% |
| Cardiac Failure |
0.8% |
| Gastrooesophageal Reflux Disease |
0.8% |
|
| Vomiting |
8.9% |
| Urinary Retention |
7.8% |
| Detachment Of Retinal Pigment Epithelium |
6.7% |
| Respiratory Failure |
6.7% |
| Urticaria |
6.7% |
| Tremor |
5.6% |
| Haematoma |
4.4% |
| Hyponatraemia |
4.4% |
| Myalgia |
4.4% |
| Oedema Peripheral |
4.4% |
| Product Quality Issue |
4.4% |
| Purpura |
4.4% |
| Renal Failure Acute |
4.4% |
| Tongue Oedema |
4.4% |
| Walking Disability |
4.4% |
| Weight Decreased |
4.4% |
| Lung Disorder |
3.3% |
| Off Label Use |
3.3% |
| Oropharyngeal Pain |
3.3% |
| Pneumonia Aspiration |
3.3% |
|
